118 related articles for article (PubMed ID: 16462869)
1. Photodynamic therapy for subretinal neovascularization in type 2A idiopathic juxtafoveolar telangiectasis.
Potter MJ; Szabo SM; Sarraf D; Michels R; Schmidt-Erfurth U
Can J Ophthalmol; 2006 Feb; 41(1):34-7. PubMed ID: 16462869
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy with verteporfin for subretinal neovascularization secondary to bilateral idiopathic acquired juxtafoveolar telangiectasis.
Hershberger VS; Hutchins RK; Laber PW
Ophthalmic Surg Lasers Imaging; 2003; 34(4):318-20. PubMed ID: 12875464
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy of subfoveal neovascular membrane in type 2A idiopathic juxtafoveolar retinal telangiectasis.
Snyers B; Verougstraete C; Postelmans L; Leys A; Hykin P
Am J Ophthalmol; 2004 May; 137(5):812-9. PubMed ID: 15126144
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy of a subretinal neovascular membrane in type 2A idiopathic juxtafoveolar retinal telangiectasis.
Potter MJ; Szabo SM; Chan EY; Morris AH
Am J Ophthalmol; 2002 Jan; 133(1):149-51. PubMed ID: 11755857
[TBL] [Abstract][Full Text] [Related]
5. Idiopathic juxtafoveal retinal telangiectasia.
Wu J; Ferrucci S
Optometry; 2008 Nov; 79(11):653-62. PubMed ID: 19811762
[TBL] [Abstract][Full Text] [Related]
6. Bilateral sequential photodynamic therapy for sub-retinal neovascularization with type 2A parafoveal telangiectasis.
Hussain N; Das T; Sumasri K; Ram LS
Am J Ophthalmol; 2005 Aug; 140(2):333-5. PubMed ID: 16086966
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy and intravitreal triamcinolone for a subretinal neovascularization in bilateral idiopathic juxtafoveal telangiectasis.
Smithen LM; Spaide RF
Am J Ophthalmol; 2004 Nov; 138(5):884-5. PubMed ID: 15531339
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
[TBL] [Abstract][Full Text] [Related]
9. Transpupillary thermotherapy for subfoveal neovascularization secondary to group 2A idiopathic juxtafoveolar telangiectasis.
Shukla D; Singh J; Kolluru CM; Kim R; Namperumalsamy P
Am J Ophthalmol; 2004 Jul; 138(1):147-9. PubMed ID: 15234300
[TBL] [Abstract][Full Text] [Related]
10. Combined photodynamic therapy and intravitreal ranibizumab as primary treatment for subretinal neovascular membrane (SRNVM) associated with type 2 idiopathic macular telangiectasia.
Rishi P; Shroff D; Rishi E
Graefes Arch Clin Exp Ophthalmol; 2008 Apr; 246(4):619-21. PubMed ID: 18193448
[TBL] [Abstract][Full Text] [Related]
11. [Clinical notes during photodynamic therapy for subretinal neovascularization].
Zolotarev AV; Malyshev AS; Fadeeva AV; Morozova IuV
Vestn Oftalmol; 2007; 123(6):43-6. PubMed ID: 18225527
[No Abstract] [Full Text] [Related]
12. Photodynamic therapy with verteporfin for subfoveal idiopathic choroidal neovascularization: one-year results from a prospective case series.
Chan WM; Lam DS; Wong TH; Lai TY; Kwok AK; Tam BS; Li KK
Ophthalmology; 2003 Dec; 110(12):2395-402. PubMed ID: 14644724
[TBL] [Abstract][Full Text] [Related]
13. Neovascular membranes associated with idiopathic juxtafoveolar telangiectasis.
Engelbrecht NE; Aaberg TM; Sung J; Lewis ML
Arch Ophthalmol; 2002 Mar; 120(3):320-4. PubMed ID: 11879135
[TBL] [Abstract][Full Text] [Related]
14. Subretinal neovascular membrane associated with type 2a idiopathic juxtafoveolar telangiectasis in pseudoxanthoma elasticum.
Parodi MB; Iacono P; Ravalico G
Graefes Arch Clin Exp Ophthalmol; 2007 Apr; 245(4):612-5. PubMed ID: 16988836
[TBL] [Abstract][Full Text] [Related]
15. Verteporfin photodynamic therapy of choroidal neovascularization in angioid streaks: one-year results of a prospective case series.
Browning AC; Chung AK; Ghanchi F; Harding SP; Musadiq M; Talks SJ; Yang YC; Amoaku WM;
Ophthalmology; 2005 Jul; 112(7):1227-31. PubMed ID: 15921757
[TBL] [Abstract][Full Text] [Related]
16. Photodynamic therapy of idiopathic and inflammatory choroidal neovascularization in young adults.
Rogers AH; Duker JS; Nichols N; Baker BJ
Ophthalmology; 2003 Jul; 110(7):1315-20. PubMed ID: 12867384
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.
Chan WM; Lam DS; Lai TY; Liu DT; Li KK; Yao Y; Wong TH
Ophthalmology; 2004 Aug; 111(8):1576-84. PubMed ID: 15288991
[TBL] [Abstract][Full Text] [Related]
18. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.
Spaide RF; Sorenson J; Maranan L
Ophthalmology; 2003 Aug; 110(8):1517-25. PubMed ID: 12917166
[TBL] [Abstract][Full Text] [Related]
19. Lack of apparent short-term benefit of photodynamic therapy in bilateral, acquired, parafoveal telangiectasis without subretinal neovascularization.
De Lahitte GD; Cohen SY; Gaudric A
Am J Ophthalmol; 2004 Nov; 138(5):892-4. PubMed ID: 15531343
[TBL] [Abstract][Full Text] [Related]
20. Resolution of macular edema in idiopathic juxtafoveal telangiectasis using PDT.
Kotoula MG; Chatzoulis DZ; Karabatsas CH; Tsiloulis A; Tsironi EE
Ophthalmic Surg Lasers Imaging; 2009; 40(1):65-7. PubMed ID: 19205501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
